Technology
Health
Biotechnology

XBiotech

$8.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.14 (-1.55%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell XBiotech and other stocks, options, ETFs, and crypto commission-free!

About

XBiotech Inc. Common Stock, also called XBiotech, is a biopharmaceutical company, which engages in development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Read More Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.

Employees
53
Headquarters
Austin, Texas
Founded
2005
Market Cap
326.98M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
111.01K
High Today
$9.20
Low Today
$8.69
Open Price
$9.05
Volume
39.27K
52 Week High
$11.74
52 Week Low
$2.13

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2015 IPO
US
North America

News

Seeking AlphaMay 2

XBiotech inks stock sales deal with Piper

XBiotech (NASDAQ:XBIT) has entered into an agreement with Piper Jaffray for the at-the-market sale of up to 4,334,453 common shares.

68

Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Available May 9, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.